Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Clinical trial NCT07216443 · RECRUITING

Trial details

NCT number: NCT07216443
Sponsor: Orca Biosystems, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute Myelodysplastic Syndromes Mixed Phenotype Acute Leukemia

Start date: 2025-12-09
Primary completion: 2027-11-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.